Small RCTs have further suggested potential harm of GLP1 RAs, mainly in patients with more advanced disease (NYHA class III–IV), possibly secondary to increased heart rate and heightened risks of arrhythmias and HF worsening.34, 35, 36. The gene discussed is GLP1R; the disease is Arrhythmia.